The 24th HUPO World Congress showed a field growing beyond mass spectrometry and starting to think in terms of impact of its ecosystems.

Expanded newborn genetic screening can diagnose hundreds of actionable conditions, allowing for earlier treatment.

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

Designed for high-resolution in-vehicle cameras, it aims to shrink boards, simplify sequencing, and improve imaging stability ...

NEJM Evidence, a journal of the New England Journal of Medicine Group, has published an article titled "Validation of a Saliva microRNA Signature for Endometriosis," dedicated to the saliva-based ...

Poster presentation highlights promising results from Phase 1b/2 TENACITY-01 study of CTD402 in T-Cell and myeloid leukemiasFindings underscore ...

Discusses Warehouse Productivity Initiatives and Digital Strategy Including LinOS Platform December 8, 2025 5:00 PM ...

NEJM Evidence, a journal of the New England Journal of Medicine Group, has published an article titled "Validation of a Saliva microRNA Signature for Endometriosis," dedicated to the saliva-based ...

Owkin shares promising validation results for BRCAura RUO, a clinical-grade research-use-only AI product designed to screen for germline BRCA1/2 mutations (gBRCAm) directly from digitized breast ...

Enhancing Ireland’s Competitiveness: The Action Plan’s focus on streamlining planning, regulatory, and legal processes will ...

Opinions expressed by Entrepreneur contributors are their own.